Health care stocks were edging higher premarket Friday with the iShares Biotechnology ETF (IBB) slightly advancing 0.1% and the Health Care Select Sector SPDR Fund (XLV) up 0.2% recently.
Centene (CNC) stock was more than 2% higher even after the company reported that it swung to a Q2 adjusted loss.
Veracyte (VCYT) is set to join the S&P SmallCap 600, effective Tuesday, to replace Triumph Group (TGI), S&P Dow Jones Indices said. Shares of Veracyte were up more than 8% premarket.
Sarepta Therapeutics (SRPT) shares were more than 13% lower after Europe's drug regulator recommended the refusal of marketing authorization for the company's Duchenne muscular dystrophy drug Elevidys.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.